JP2004532223A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532223A5
JP2004532223A5 JP2002582927A JP2002582927A JP2004532223A5 JP 2004532223 A5 JP2004532223 A5 JP 2004532223A5 JP 2002582927 A JP2002582927 A JP 2002582927A JP 2002582927 A JP2002582927 A JP 2002582927A JP 2004532223 A5 JP2004532223 A5 JP 2004532223A5
Authority
JP
Japan
Prior art keywords
alkyl
spiro
piperidine
group
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002582927A
Other languages
English (en)
Japanese (ja)
Other versions
JP4489354B2 (ja
JP2004532223A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/012357 external-priority patent/WO2002085354A1/en
Publication of JP2004532223A publication Critical patent/JP2004532223A/ja
Publication of JP2004532223A5 publication Critical patent/JP2004532223A5/ja
Application granted granted Critical
Publication of JP4489354B2 publication Critical patent/JP4489354B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002582927A 2001-04-18 2002-04-18 スピロインデンおよびスピロインダン化合物類 Expired - Fee Related JP4489354B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28467001P 2001-04-18 2001-04-18
PCT/US2002/012357 WO2002085354A1 (en) 2001-04-18 2002-04-18 Spiroindene and spiroindane compounds

Publications (3)

Publication Number Publication Date
JP2004532223A JP2004532223A (ja) 2004-10-21
JP2004532223A5 true JP2004532223A5 (cg-RX-API-DMAC7.html) 2005-12-22
JP4489354B2 JP4489354B2 (ja) 2010-06-23

Family

ID=23091075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002582927A Expired - Fee Related JP4489354B2 (ja) 2001-04-18 2002-04-18 スピロインデンおよびスピロインダン化合物類

Country Status (13)

Country Link
US (1) US6828440B2 (cg-RX-API-DMAC7.html)
EP (2) EP2033644A1 (cg-RX-API-DMAC7.html)
JP (1) JP4489354B2 (cg-RX-API-DMAC7.html)
AT (1) ATE413175T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002256282C1 (cg-RX-API-DMAC7.html)
CA (1) CA2443938C (cg-RX-API-DMAC7.html)
CY (1) CY1108731T1 (cg-RX-API-DMAC7.html)
DE (1) DE60229736D1 (cg-RX-API-DMAC7.html)
DK (1) DK1385514T5 (cg-RX-API-DMAC7.html)
ES (1) ES2316559T3 (cg-RX-API-DMAC7.html)
PT (1) PT1385514E (cg-RX-API-DMAC7.html)
SI (1) SI1385514T1 (cg-RX-API-DMAC7.html)
WO (1) WO2002085354A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6374762B1 (en) * 1997-10-27 2002-04-23 Correct Craft, Inc. Water sport towing apparatus
EP1470126A1 (en) * 2002-01-28 2004-10-27 Pfizer Inc. N-substituted spiropiperidine compounds as ligands for orl-1 receptor
US7566728B2 (en) 2002-03-29 2009-07-28 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
CA2520114A1 (en) 2003-04-04 2004-10-21 Merck & Co., Inc. Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
GB0328906D0 (en) * 2003-12-12 2004-01-14 Syngenta Participations Ag Chemical compounds
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
WO2005092858A2 (en) 2004-03-29 2005-10-06 Pfizer Japan Inc. Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
CN1984663A (zh) 2004-03-29 2007-06-20 南佛罗里达大学 用曲西瑞宾和相关化合物有效治疗肿瘤和癌症
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US7879834B2 (en) * 2004-08-19 2011-02-01 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
US7786141B2 (en) * 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
JP2008521825A (ja) * 2004-11-29 2008-06-26 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
WO2007028638A1 (en) * 2005-09-09 2007-03-15 Euro-Celtique S.A. Fused and spirocycle compounds and the use thereof
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
CA2634456A1 (en) * 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
RU2008137583A (ru) * 2006-02-22 2010-03-27 Вертекс Фармасьютикалз Инкорпорейшн (Us) Спиропиперидины в качестве модуляторов мускариновых рецепторов
US8003660B2 (en) 2006-02-22 2011-08-23 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7858790B2 (en) * 2006-06-29 2010-12-28 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
CN101553231A (zh) * 2006-08-15 2009-10-07 弗特克斯药品有限公司 毒蕈碱受体调节剂
US7786107B2 (en) * 2006-08-18 2010-08-31 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
WO2009027820A2 (en) 2007-08-31 2009-03-05 Purdue Pharma L.P. Substituted-quinoxaline-type-piperidine compounds and the uses thereof
JP2010540640A (ja) * 2007-10-03 2010-12-24 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン作用性レセプターのモジュレーター
EP2265588B1 (en) * 2008-02-27 2013-06-26 Vitae Pharmaceuticals, Inc. INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1
RS52590B2 (sr) 2008-07-21 2018-05-31 Purdue Pharma Lp Jedinjenja tipa supstituisanog hinoksalina sa premošćenim piperidinom i njihova upotreba
EP2403337A4 (en) * 2009-03-03 2012-08-15 Univ Vanderbilt ALKYLSULFONYL-2,3-DIHYDROSPIRO [INDENE-1,4'-PIPERIDINE] ANALOGUES AS GLYT1 INHIBITORS, METHODS OF MAKING THEM AND USE THEREOF IN THE TREATMENT OF PSYCHIATRIC DISORDERS
AR078522A1 (es) * 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US10118927B2 (en) 2012-12-27 2018-11-06 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
WO2018023017A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of treating prostate cancer

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1335831A (fr) 1962-10-09 1963-08-23 Res Lab Dr C Janssen Nv Procédé de préparation de nu-(3, 3-diphényl-3-alcanoyl)-propylspiro
US3161645A (en) 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
US3325499A (en) 1964-11-02 1967-06-13 Mcneilab Inc 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone
US3666764A (en) * 1970-08-26 1972-05-30 Mead Johnson & Co Spiroindenylpiperidines
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4329353A (en) 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
JPS58180481A (ja) 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
JPS60120872A (ja) 1983-12-01 1985-06-28 Kyowa Hakko Kogyo Co Ltd 新規なヘテロ環状化合物及び強心剤
EP0445974A3 (en) * 1990-03-05 1992-04-29 Merck Sharp & Dohme Ltd. Spirocyclic antipsychotic agents
DK78692D0 (da) 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
DE69412067T2 (de) * 1993-01-28 1999-03-25 Merck & Co., Inc., Rahway, N.J. Substituierte spiro-azaringen als tachykinine rezeptor antagonisten
US5457207A (en) 1993-10-05 1995-10-10 Regents Of The University Of Minnesota Spirovesamicols
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
AU688498B2 (en) 1994-04-14 1998-03-12 Merck & Co., Inc. Alpha1c adrenergic receptor antagonists
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
US5767118A (en) 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
US5574044A (en) 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
ATE301457T1 (de) 1995-06-12 2005-08-15 Searle & Co Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
US6150355A (en) 1995-09-13 2000-11-21 Kyowa Hakko Kogyo Co., Ltd. Phenylpiperidine derivative
DE69736776T2 (de) 1996-04-19 2007-01-18 Neurosearch A/S 1-(4-piperidyl)-benzimidazole mit neurotropher aktivität
WO1998025604A1 (en) 1996-12-13 1998-06-18 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US6063796A (en) 1997-04-04 2000-05-16 Merck & Co., Inc. Somatostatin agonists
CA2291094C (en) 1997-05-30 2008-02-26 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivative
JPH10330377A (ja) 1997-06-02 1998-12-15 Kyowa Hakko Kogyo Co Ltd ピペリジン誘導体
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
GB9718833D0 (en) * 1997-09-04 1997-11-12 Merck Sharp & Dohme Therapeutic agents
SI0921125T1 (en) 1997-12-05 2002-04-30 F. Hoffmann-La Roche Ag 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
US6166209A (en) * 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
US6013644A (en) * 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
PL342046A1 (en) 1998-01-19 2001-05-21 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidine compounds as agonists of orl1 receptor
NZ507760A (en) 1998-03-26 2002-10-25 Japan Tobacco Inc Amide derivatives and nociceptin antagonists
JP2002515503A (ja) 1998-05-18 2002-05-28 ノボ ノルディスク アクティーゼルスカブ オピオイド受容体のサブタイプへの高い親和性を有する新規1,3,8−トリアザスピロ〔4,5〕デカノン
WO1999065494A1 (en) 1998-06-15 1999-12-23 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ID29137A (id) 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
JP2001011050A (ja) 1999-04-30 2001-01-16 Sankyo Co Ltd 含窒素飽和複素環化合物
AU7716600A (en) * 1999-09-30 2001-04-30 Merck & Co., Inc. Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
JP2004531456A (ja) 2000-09-06 2004-10-14 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 置換ピラゾールを用いてアレルギーを治療する方法
WO2002026714A1 (en) * 2000-09-27 2002-04-04 Takeda Chemical Industries, Ltd. Spiro compounds

Similar Documents

Publication Publication Date Title
JP2004531531A5 (cg-RX-API-DMAC7.html)
JP2004531532A5 (cg-RX-API-DMAC7.html)
JP2005518330A5 (cg-RX-API-DMAC7.html)
CA2443938A1 (en) Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
SU1138032A3 (ru) Способ получени производных бициклического пиримидин-5-она или их солей с фармацевтически приемлемыми кислотами,или их цис- или транс-изомеров
RU2003133454A (ru) Аналоги ноцицептина
RU2495873C2 (ru) Новое урациловое соединение или его соль, обладающие ингибирующей активностью относительно дезоксиуридинтрифосфатазы человека
RU2667907C2 (ru) ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ
PE20211703A1 (es) Compuesto derivado heterotriciclico novedoso y uso del mismo
RU2014123434A (ru) Фармацевтические соединения
RU2444362C2 (ru) Лекарственное средство
CO5580770A2 (es) Compuestos de quinolina terapeuticos con propiedades antagonistas de 5-ht
KR20190080897A (ko) 치환된 피리디논 함유 트리시클릭 화합물, 및 그의 사용 방법
RU2004126612A (ru) Хиназолиновые соединения
JP2004002414A5 (cg-RX-API-DMAC7.html)
DK110395A (da) 1-Substituerede 4-(4-(lavere alkyl)sulfonylaminobenzoyl)-piperidiner, farmakologisk acceptable salte deraf samt farmaceutiske præparater med indhold af sådanne
CO5580826A2 (es) Compuestos de quinolona terapeuticos con propiedades antagonistas de 5ht
RU2010111729A (ru) Ингибиторы активности протеинтирозинкиназы
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
DE60219672D1 (de) Imidazopyridine, -pyrimidine und -triazine als gaba-a alpha 5 rezeptor subtyp liganden zur verbesserung kognitiver eigenschaften
JP2013520473A5 (cg-RX-API-DMAC7.html)
RU2009119421A (ru) Производные 2-фенил-6-аминокарбонилпиримидина и их применение в качестве антагонистов тромбоцитарного рецептора адф (p2y12 рецептора)
NO174050C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranforbindelser
JP2004517130A5 (cg-RX-API-DMAC7.html)
ZA200404544B (en) Use of endothelin receptor antagonists in the treatment of tumour diseases.